Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study involves GLQ223 administration to patients who have not previously been exposed to it, but who have received at least 9 months of zidovudine therapy. Efficacy evaluations will include survival, opportunistic infections, T4 cell count, and assessments of viral load.
Critère d'inclusion
- HIV Infections